• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰弱对老年人药代动力学的影响:利用庆大霉素群体药代动力学模型研究肾小球滤过导致的肾脏药物清除率变化。

The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.

作者信息

Johnston Claire, Hilmer Sarah N, McLachlan Andrew J, Matthews Slade T, Carroll Peter R, Kirkpatrick Carl M

机构信息

Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

出版信息

Eur J Clin Pharmacol. 2014 May;70(5):549-55. doi: 10.1007/s00228-014-1652-7. Epub 2014 Feb 14.

DOI:10.1007/s00228-014-1652-7
PMID:24522409
Abstract

PURPOSE

Frailty, a multifactorial biological syndrome characterized by a cumulative dysregulation of physiological processes, is associated with changes in pharmacokinetics and pharmacodynamics. The aim of this study was to quantify the effect of frailty on glomerular filtration of drugs, using the probe drug gentamicin.

METHODS

Gentamicin concentrations and clinical data including the Reported Edmonton Frail Scale score were pooled from two prospective observational inpatient studies, one on prophylactic gentamicin for urologic surgery and one on therapeutic gentamicin for the empiric treatment of sepsis. Population pharmacokinetic modeling was performed using non-linear mixed effects modeling (NONMEM program) to determine the impact of frailty on gentamicin clearance.

RESULTS

A one-compartment linear pharmacokinetic model best described the data and the addition of frailty to the model reduced the random variability in gentamicin clearance by 12 % after adjustment for renal function (estimated creatinine clearance using lean body weight) and lean body weight. Frail patients had an approximately 12 % lower (bootstrapping results: 14 % median) gentamicin clearance than non-frail patients (calculated as a fractional effect of frailty).

CONCLUSIONS

Frailty may independently predict reduced clearance of gentamicin in older patients. Frailty could be considered in the development of dosing guidelines for drugs that undergo significant excretion through glomerular filtration.

摘要

目的

衰弱是一种以生理过程累积失调为特征的多因素生物综合征,与药代动力学和药效学的变化有关。本研究的目的是使用探针药物庆大霉素来量化衰弱对药物肾小球滤过的影响。

方法

从两项前瞻性观察性住院患者研究中汇总庆大霉素浓度和临床数据,包括埃德蒙顿衰弱量表报告得分,一项研究是关于泌尿外科手术预防性使用庆大霉素,另一项研究是关于经验性治疗脓毒症的治疗性使用庆大霉素。使用非线性混合效应模型(NONMEM程序)进行群体药代动力学建模,以确定衰弱对庆大霉素清除率的影响。

结果

单室线性药代动力学模型最能描述数据,在调整肾功能(使用瘦体重估计肌酐清除率)和瘦体重后,将衰弱因素添加到模型中可使庆大霉素清除率的随机变异性降低12%。衰弱患者的庆大霉素清除率比非衰弱患者低约12%(自举结果:中位数为14%)(计算为衰弱的分数效应)。

结论

衰弱可能独立预测老年患者庆大霉素清除率降低。在制定通过肾小球滤过进行大量排泄的药物给药指南时,应考虑衰弱因素。

相似文献

1
The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.衰弱对老年人药代动力学的影响:利用庆大霉素群体药代动力学模型研究肾小球滤过导致的肾脏药物清除率变化。
Eur J Clin Pharmacol. 2014 May;70(5):549-55. doi: 10.1007/s00228-014-1652-7. Epub 2014 Feb 14.
2
Gentamicin pharmacokinetics in old age and frailty.老年和虚弱患者的庆大霉素药代动力学。
Br J Clin Pharmacol. 2011 Feb;71(2):224-31. doi: 10.1111/j.1365-2125.2010.03825.x.
3
Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.庆大霉素、妥布霉素和万古霉素从新生儿到成人清除率的同步药代动力学建模:建立肾小球滤过成熟的半生理功能模型。
Pharm Res. 2014 Oct;31(10):2643-54. doi: 10.1007/s11095-014-1361-z. Epub 2014 May 2.
4
Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.评估氨基糖苷类药物剂量及估算肾小球滤过率对确定庆大霉素和妥布霉素曲线下面积及清除率的作用。
Intern Med J. 2015 Mar;45(3):319-29. doi: 10.1111/imj.12684.
5
Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.危重症患者中庆大霉素浓度的影响因素:群体药代动力学分析。
Int J Antimicrob Agents. 2017 Feb;49(2):204-211. doi: 10.1016/j.ijantimicag.2016.10.022. Epub 2016 Dec 16.
6
Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.群体药代动力学:针对医学重症监护病房制定庆大霉素给药剂量线图
Ann Pharmacother. 1993 Feb;27(2):151-4. doi: 10.1177/106002809302700202.
7
Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.新生儿缺氧缺血性脑病行低温治疗时的庆大霉素药代动力学和剂量。
Pharmacotherapy. 2013 Jul;33(7):718-26. doi: 10.1002/phar.1263. Epub 2013 Apr 1.
8
Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.庆大霉素在接受每日一次给药的住院患者中的群体药代动力学。
Int J Antimicrob Agents. 2004 Mar;23(3):291-5. doi: 10.1016/j.ijantimicag.2003.07.010.
9
Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.庆大霉素在957例不同肾功能患者中每日给药一次的药代动力学。
Br J Clin Pharmacol. 1999 Jun;47(6):637-43. doi: 10.1046/j.1365-2125.1999.00938.x.
10
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.利用群体药代动力学在急性肾损伤危重症患者行每日持续缓慢血液滤过时调整庆大霉素剂量。
Antimicrob Agents Chemother. 2010 Sep;54(9):3635-40. doi: 10.1128/AAC.00222-10. Epub 2010 Jun 14.

引用本文的文献

1
Population Pharmacokinetics of Meropenem Across the Adult Lifespan.美罗培南在成年期的群体药代动力学。
Clin Pharmacokinet. 2025 Feb;64(2):229-241. doi: 10.1007/s40262-024-01465-1. Epub 2024 Dec 16.
2
An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients.老年患者抗菌药物的药代动力学及剂量优化研究
Front Pharmacol. 2024 Sep 30;15:1396994. doi: 10.3389/fphar.2024.1396994. eCollection 2024.
3
Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic-Pharmacodynamic Modeling.

本文引用的文献

1
Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.老年人口的药物政策——欧洲药品管理局的老年医学药物战略。
N Engl J Med. 2012 Nov 22;367(21):1972-4. doi: 10.1056/NEJMp1209034.
2
Physiologically based pharmacokinetic modeling at the extremes of age.基于生理学的极端年龄阶段药代动力学建模。
Clin Pharmacol Ther. 2013 Feb;93(2):148. doi: 10.1038/clpt.2012.176. Epub 2012 Nov 21.
3
Medication prescribing in frail older people.老年人虚弱者的药物处方。
通过群体药代动力学-药效学模型探索雷贝拉唑在不同性别间的药代动力学差异。
Biomedicines. 2023 Nov 10;11(11):3021. doi: 10.3390/biomedicines11113021.
4
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review.各种患者人群中庆大霉素的临床药代动力学及治疗革兰氏阴性感染的最佳给药剂量的后果:更新综述。
Clin Pharmacokinet. 2022 Aug;61(8):1075-1094. doi: 10.1007/s40262-022-01143-0. Epub 2022 Jun 27.
5
Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis.衰弱老年人多次口服扑热息痛后药代动力学的高度变化:群体药代动力学分析。
Drugs Aging. 2022 Jan;39(1):83-95. doi: 10.1007/s40266-021-00912-z. Epub 2021 Dec 17.
6
Incorporating pharmacokinetic data into personalised prescribing for older people: challenges and opportunities.将药代动力学数据纳入老年人个体化给药方案:挑战与机遇。
Eur Geriatr Med. 2021 Jun;12(3):435-442. doi: 10.1007/s41999-020-00437-5. Epub 2021 Jan 8.
7
Population Pharmacokinetic Study of Ceftriaxone in Elderly Patients, Using Cystatin C-Based Estimates of Renal Function To Account for Frailty.基于胱抑素 C 估计的肾功能评估老年患者头孢曲松的群体药动学研究:考虑虚弱因素。
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00874-20.
8
Frailty as an Immune-Mediated Condition That Leads to an Increased Risk of Acute Cellular Rejection in Liver Transplant Recipients.衰弱作为一种免疫介导的病症,会导致肝移植受者急性细胞排斥反应风险增加。
Clin Liver Dis (Hoboken). 2020 Jun 30;15(6):243-245. doi: 10.1002/cld.960. eCollection 2020 Jun.
9
Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation.肝移植后 3 个月内,虚弱与急性细胞排斥反应发生率增加相关。
Liver Transpl. 2020 Mar;26(3):390-396. doi: 10.1002/lt.25669. Epub 2020 Feb 3.
10
Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions.给老年人开药——如何考虑衰老对人体器官和身体功能的影响。
Br J Clin Pharmacol. 2020 Oct;86(10):1921-1930. doi: 10.1111/bcp.14094. Epub 2019 Dec 16.
Eur J Clin Pharmacol. 2013 Mar;69(3):319-26. doi: 10.1007/s00228-012-1387-2. Epub 2012 Sep 11.
4
High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS.采用自动化 SPE 与 LC-MS/MS 联用技术的同时定量检测血浆中吗啡、芬太尼、咪达唑仑及其主要代谢物浓度的高通量分析方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 15;903:126-33. doi: 10.1016/j.jchromb.2012.07.005. Epub 2012 Jul 20.
5
The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomes.2011 年 ESPEN 阿维德·雷特林德讲座:癌症恶病质:转化研究对以患者为中心结局的潜在影响。
Clin Nutr. 2012 Oct;31(5):577-82. doi: 10.1016/j.clnu.2012.06.012. Epub 2012 Jul 21.
6
Measurement of CYP1A2 activity: a focus on caffeine as a probe.CYP1A2 活性的测定:以咖啡因作为探针的研究。
Curr Drug Metab. 2012 Jun 1;13(5):667-78. doi: 10.2174/1389200211209050667.
7
Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project.寻找虚弱的操作性定义:基于德尔菲法的共识声明:虚弱操作性定义共识会议项目。
J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):62-7. doi: 10.1093/gerona/gls119. Epub 2012 Apr 16.
8
Estimation of lean body weight in older women with hip fracture.老年髋部骨折女性瘦体重的评估。
J Nutr Health Aging. 2012 Feb;16(2):188-92. doi: 10.1007/s12603-011-0100-y.
9
High-risk prescribing and incidence of frailty among older community-dwelling men.高风险处方与老年社区居住男性虚弱的发生。
Clin Pharmacol Ther. 2012 Mar;91(3):521-8. doi: 10.1038/clpt.2011.258. Epub 2012 Feb 1.
10
Frailty markers predicting emergency department visits in a community-dwelling sample of vulnerable seniors in Montreal. frail 标志物预测蒙特利尔弱势老年人社区居住样本中的急诊科就诊情况。
Can J Aging. 2011 Dec;30(4):647-55. doi: 10.1017/S0714980811000511. Epub 2011 Oct 3.